Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)-Reference-Cited by-同舟云学术

Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)

Published:2019-12-27 Issue:2 Volume:188 Page:240-248
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Pettengell Ruth¹,Długosz‐Danecka Monika²,Andorsky David³^ORCID,Belada David⁴,Georgiev Pencho⁵,Quick Donald⁶,Singer Jack W.⁷⁸,Singh Simran B.⁷⁸,Pallis Athanasios⁹,Egorov Anton⁹^ORCID,Salles Gilles¹⁰

Affiliation:

1. St. George's Hospital London UK

2. Department of Haematology Jagiellonian University Krakow Poland

3. Rocky Mountain Cancer CentersUS Oncology Research Boulder CO USA

4. Clinical Haematology 4th Department of Internal Medicine Charles University, Hospital and Faculty of Medicine Hradec Králové Czech Republic

5. Clinic of Oncology and Haematology University Multiprofile Hospital for Active Treatment "Sveti Georgi" and Medical University Plovdiv Bulgaria

6. Joe Arrington Cancer Research Treatment Center Lubbock TX USA

7. CTI Biopharma Seattle WA USA

8. Elson S. Floyd School of Medicine Washington State University WA USA

9. Institut de Recherches Internationales Servier SuresnesFrance

10. Haematology Department Hospices Civils de LyonUniversité Claude Bernard Lyon‐1 Pierre‐Bénite France

Publisher